Abstract：
Over the past 20 years, plasma has become a medical treatment characterized as \"liquid gold\" to signal its lifesaving potential. Through a manufacturing process termed fractionation, plasma, collected through blood donation, is turned into Plasma Derived Medical Products (PDMPs). The World Health Organization (WHO) has underlined the importance of PDMPs for global health care, including a number of PDMPs on the WHO Model List of Essential Medicines. The process of collecting plasma from a donor, manufacturing plasma derived treatments, and distributing those treatments globally requires the coordination of multiple social actors operating in different social, political and economic contexts, but has received little attention in scholarly literature on public policy or the social sciences. This paper will introduce a set of analytic questions and concepts that can direct a sociology of plasma products. We build on the behavioral turn in the policy sciences to identify relevant policy questions emerging from this field and offer the analytic tools necessary to investigate how different social actors in this space make meaning of plasma. To do this, we will draw on key concepts in the sociology of health and illness.
摘要：
在过去的20年里,等离子体已成为一种以“液态金”为特征的医疗手段，以表明其挽救生命的潜力。通过称为分馏的制造过程，等离子体,通过献血采集,变成血浆衍生医疗产品(PDMPs)。世界卫生组织（WHO）强调了PDMP对全球医疗保健的重要性，包括世卫组织基本药物标准清单上的一些PDMP。从供体收集血浆的过程，制造等离子体衍生处理，在全球范围内分配这些治疗需要协调在不同社会中运作的多个社会行为者，政治和经济背景，但在公共政策或社会科学的学术文献中很少受到关注。本文将介绍一组可以指导等离子体产品社会学的分析问题和概念。我们以政策科学中的行为转向为基础，以识别该领域出现的相关政策问题，并提供必要的分析工具，以研究该领域中不同的社会行为者如何产生等离子体的意义。要做到这一点，我们将借鉴健康和疾病社会学的关键概念。
